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OXIDATIVE STRESS BIOMARKERS IN CORTICAL TISSUE ASSOCIATED 
WITH POST TRAUMATIC STRESS DISORDER 
VICTOR VENTRANO 
ABSTRACT 
 
Background: Mild	Traumatic	Brain	Injury	(mTBI)	is	increasingly	recognized	as	an	adverse	health	consequence	for	athletes	who	participate	in	contact	sports,	such	as	football	or	boxing,	as	well	as	military	personnel	who	are	exposed	to	concussive	blasts	during	training	and	combat	operations.  A consequence of this repetitive brain 
injury can be the development of a number of neurodegenerative diseases, particularly 
chronic traumatic encephalopathy (CTE), a disease involving the buildup of toxic 
phosphorylated tau (p-tau) in the pre-frontal cortical tissue.  Additionally, it has been 
found that military personnel suffering repeated mTBI from primary blast concussions 
are prone to development of post traumatic stress disorder (PTSD), a disease that is 
becoming increasingly common among returning service members.  Because mTBI is a 
common cause for both PTSD and CTE, it is possible for the two diseases to manifest 
comorbidly in an individual.  Though much is known about PTSD psychologically and 
CTE neuropathologically, little is known about the overlapping effect of the two diseases 
together as well as PTSD neuropathologically.  What is known, however, is that 
aquaporin-4; a channel involved in the movement of water through the blood brain 
barrier, is often affected by CTE and may play a role in PTSD as well. 
		 vi 
Objective: The objective of this study was to primarily to analyze	the	disruption	of	aquaporin-4	around	cerebral	blood	vessels	due	to	chronic	traumatic	encephalopathy.		A	secondary	objective	of	this	project	was	to	determine	if	any	unique	physiopathological	biomarkers	exist	in	PTSD	and	if	the	effects	of	CTE	are	exacerbated	when	present	comorbidly	with	PTSD. 
Methods: This study involved the analysis of multiple cohorts that had suffered from 
CTE, PTSD and CTE comorbidly, or neither disease as a control.  In order to assess the 
primary objective, two cohorts, a CTE-only and a control, were analyzed to determine the 
effect of p-tau on aquaporin-4 directly around cerebral vessels in the pre-frontal cortex.  
The samples were cut from blocks and stained for the desired markers.  Following 
staining, images were taken using a confocal microscope and the images were analyzed 
using Amaris and FIJI.  For the secondary objective, samples were prepared in a similar 
way with three cohorts: CTE-only, CTE+PTSD comorbid, and a control.  Images were 
obtained and processed in the same way. 
Results: It was found that aquaporin-4 density is significantly reduced around both 
arterial and venous lesional vessels.  Additionally, it was found that p-tau	was	more	readily	deposited	in	the	depths	of	the	sulci	of	the	pre-frontal	cortex	due	to	the	unique	forces	caused	by	repeated	mTBI.  However, PTSD was not found to 
significantly compound the disease when comorbidly present with CTE nor to have a 
unique biomarkers present. 
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Conclusion: P-tau present in CTE causes a significant reduction in aquaporin-4 around 
cerebral vessels in the pre-frontal cortex, thereby potentially inhibiting the movement of 
fluids and clearance of metabolites into and out of the brain.  Additionally, p-tau is more 
readily deposited in the depths of the sulci of the pre-frontal cortex.  However, PTSD 
does not compound the CTE disease process when comorbidly present.  
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INTRODUCTION 	
Repeated Traumatic Brain Injury is a Problem in Athletes and Military Personnel 
 Mild Traumatic Brain Injury (mTBI) is increasingly recognized as an adverse 
health consequence for athletes who participate in contact sports, such as football or 
boxing, as well as military personnel who are exposed to concussive blasts during 
training and combat operations.  TBI is defined as “an insult to the brain caused by an 
external force that may produce diminished or altered states of consciousness, which 
results in impaired cognitive abilities or physical functioning” (Edwards III 2016) and is 
categorized into three categories: mild, moderate, or severe based on the presence and 
duration of three factors being loss of consciousness, posttraumatic amnesia, and 
alteration of consciousness (Reid and Velez 2015).  Mild TBI is diagnosed when any of 
these factors are experienced due to external forces (Reid and Velez 2015).  Many of 
those affected are often exposed to repeated TBI, both blunt force through hits to the head 
and blast related, such as concussions caused by explosive devices.  Although blast 
injuries fall into four general categories for bodily injury, the consideration for blast 
injury causing brain damage is specific to blast shock wave and pressure as these are the 
forces that encounter the skull (DePalma 2015).   
When repeated mTBI occur in military personnel, the typical mechanism of injury 
is “brain contusions caused by ‘coup and contrecoup’ brain motion within the skull.” 
(Gennerelli 2005)  During acute TBI, the injurious forces generate intracranial pressure 
gradients that generate shearing and strain forces that stretch and damage axons causing 
diffuse axonal injury, as well as damage to blood vessels and glial cells such as astrocytes 
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(Blennow et al. 2016).  Injury to the axons then causes a cascade of effects such as 
changes in axolemma permeability, ionic shifts, and release of caspases and calpains that 
trigger the misfolding, truncation, and hyperphosphorylation of many proteins, including 
tau (McKee et al. 2009).  In addition to the axonal damage, the trauma forces can cause 
damage to blood vessels in the brain as well as the blood brain barrier (BBB), causing 
inflammation and microhemorrhages.  Repeated acute TBIs can eventually lead to the 
overload of normal clearance functions causing hyperphosphorylated tau (p-tau) to build 
up as a toxic metabolite (McKee et al. 2009).  If the external force causing the injury is 
great enough to cause brain rotation, the result is more severe brain damage and can 
include subarachnoid hemorrhage, subdural and epidural hematoma, brain contusion and 
laceration, shearing of nerve fibers, or intracranial hypertension (DePalma 2015).  These 
injuries are the hallmark injuries of Operation Enduring Freedom (OEF) and Operation 
Iraqi Freedom (OIF) and compromise neuronal function as well as contribute to 
susceptibility to behavioral symptoms included in post-traumatic stress disorder (PTSD) 
(Devoto et al. 2016).  When concerned with athletes, however, repetitive 
impact/acceleration injuries cause “in addition to acute concussive effects, chronic 
traumatic encephalopathy related to deposition of tau and other proteins that promote late 
neurodegenerative disease.” (McKee et al. 2009)   
With upwards of 2 million servicemen deployed and millions of civilian athletes 
at risk of exposure, understanding repeated TBI and how it impacts the brain in relation 
to the development of chronic traumatic encephalopathy (CTE) is integral to the 
development of treatment and preventative care. 
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Repeated Traumatic Brain Injury Leads to Chronic Traumatic Encephalopathy 
It is now well documented that repeated mTBI is one of the main causes of 
chronic traumatic encephalopathy (CTE).  Through repeated TBIs, such as in contact 
sports and military operations, athletes and military personnel can develop CTE causing 
the accumulation of neurofibrillary tangles (NFT) in the brain that lead to various 
neurodegenerative diseases.  Specifically for CTE, the neurodegenerative disorder that 
develops involves the destruction of neurons in the brain as well as the blood vessels 
through the deposition and buildup of tau protein, a toxic metabolite.  The pattern of tau 
buildup in the brain is similar to other neurodegenerative diseases such as Alzheimer’s as 
it can be deposited either diffusely in astrocytes or as NFTs in the neurons.  However, the 
early, focal perivascular changes in CTE differs from the p-tau pathology in early 
Alzheimer type tissue and, unlike in preclinical Alzheimer’s disease (AD), medial 
temporal lobe p-tau pathology is not an early or preclinical manifestation of CTE (Stein, 
Alvarez, and McKee 2014).  Tau is an important protein in the brain for axonal 
stabilization, neuronal development, and neuronal polarity, but becomes pathological 
when it misfolds and aggregates.  Hyperphosphorylation of the tau then leads to 
destabilization of microtubules and interruption of axonal transport, as well as synaptic 
dysfunction (Collins-Praino and Corrigan 2017).  In CTE, tau pathology is often seen in a 
perivascular location, particularly in the depths of sulci (Figure 1).  Though subclinical 
head injuries sustained through sports can produce CTE, “a single TBI also results in 
abnormal tau pathology in the depths of sulci in a large proportion of long-term survivors 
of TBI.” (Ghajari, Hellyer, and Sharp 2017)  Though the risk factors for the development 
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of CTE from TBI are variable, it is known that age, extent, nature, and timing of trauma, 
genetics, and other health-related factors are contributing.
 
Figure 1. A Coronal Section of the Pre-Frontal Cortex Affected by CTE. This section 
demonstrates the deposition of p-tau during CTE, primarily focused in the sulci of the 
pre-frontal cortex. Courtesy of Dr. Ann McKee. 
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Often, CTE manifests itself both clinically and neuropathologically at varying 
degrees of severity.  Clinically, CTE is known to be associated with symptoms such as 
irritability, impulsivity, aggression, short-term memory loss and increased suicidality 
beginning 8-10 years after suffering repeated mTBI (McKee et al. 2013).  In addition to 
the clinical features, the neuropathological features of CTE have also been determined.  
Often, chronic traumatic encephalopathy will manifest with:  
Atrophy of the cerebral cortex, medial temporal lobe, diencephalon and 
mammillary bodies with enlarged vesicles; cavum septum pellucidum, often with 
fenestrations; extensive p-tau immunoreactive neurofibrillary tangles and 
astrocytic tangles in the frontal and temporal cortices, particularly around small 
cerebral vessels and at the depths of the cerebral sulci; extensive p-tau 
immunoreactive neurofibrillary tangles present in limbic regions, diencephalon 
and brainstem nuclei; extensive degeneration of axons and white matter fiber 
bundles; TAR DNA-binding protein 43 (TDP-43) immunoreactive intraneuronal 
and intraglial inclusions and neurites in most cases and a relative absence of 
amyloid-β peptide deposits. (p. 44; McKee et al. 2013) 
The severity of the damage caused by CTE is determined by post mortem autopsy to 
determine the stage, I-IV, present through analysis of tissue degradation and 
presence/abundance of p-tau tangles. 
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History and Epidemiology of PTSD 
	 Post-traumatic stress disorder is a condition defined, according to the American 
Psychiatric Association (APA), as “the development of characteristic symptoms 
following exposure to one or more traumatic events” (APA 2013).  The first official 
recognition of PTSD, as it is known today, occurred in 1980 following the Vietnam War 
by the APA in the Diagnostic and Statistical Manual of Mental Disorders III (DSM III) 
(Howlett and Stein 2016). In its initial definition, the traumatic event triggering the onset 
of PTSD was conceptualized to be a stressor outside of normal human experiences, such 
as war or torture (Friedman 2013).  These initial stressors were considered to be separate 
from normal life stresses such as divorce and serious illness.  As understanding of PTSD 
grew, the symptoms and criteria were revised.  In the DSM-IV, the PTSD diagnostic 
criteria were revised to include a “history of exposure to a traumatic event and symptoms 
for each of three symptom clusters: intrusive recollections, avoidant/numbing symptoms, 
and hyper-arousal symptoms” as well as criteria for duration of symptoms and distress or 
functional impairment from symptoms (Friedman 2013).  In the most recent edition of the 
DSM in 2013, the APA changed PTSD from just being a fear-based anxiety disorder to 
include “anhedonic/dysmorphic” presentations, which are marked by negative cognitions, 
mood states, and disruptive behavioral symptoms (Freidman 2013).  Additionally, 
PTSD’s categorization as an anxiety disorder was changed to being a trauma and stress-
related disorder (Friedman 2013). 
  The longer PTSD has been officially defined and recognized, the more prominent 
a diagnosis it has become.  In a recent study from the National Comorbidity Survey 
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Replication, it was found that lifetime PTSD prevalence rates in Americans are 3.6% in 
men and 9.7% in women, with these rates being significantly higher in post-conflict areas 
(Nock et al. 2010).  These statistics represent the civilian population prevalence of the 
United States from events such as rape, assault, natural disasters, and vehicle accidents 
(Howlett and Stein 2016).  For civilians, risk factors for the development of PTSD in 
individuals exposed to traumatic events include “preexisting psychiatric disorders, family 
history of psychiatric disorders, poor social support, low IQ, and female gender” 
(Howlett and Stein 2016). 
 In military personnel, the rates of PTSD prevalence are believed to be higher due 
to the nature of their profession.  PTSD is estimated	to	affect	approximately	20%	of	returning	Operation	Enduring	Freedom	and	Operation	Iraqi	Freedom	service	members.		According	to	the	Army	Study	to	Assess	Risk	and	Resilience	in	Service	members	(Army	STARRS),	there	is	an	increased	risk	in	the	development	of	PTSD	for	male	military	personnel,	Caucasian	ethnicity,	and	junior	enlisted	with	increased	risk	also	applying	to	deployed	women,	soldiers	demoted	in	the	past	two	years,	and	soldiers	without	a	high	school	diploma.		This	higher	prevalence	is	believed	to	be	positively	associated	with	level	of	combat	exposure	(Howlett	and	Stein	2016).		 
 
Chronic Traumatic Encephalopathy can be Comorbid with PTSD  
 Comorbidity is a condition when more than one chronic disease is present at the 
same time in an individual, potentially exacerbating one of the existing conditions. 
Because of the risk for repeated TBI in the military theatre, it is possible for military 
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personnel to be susceptible to development of both CTE through repeated TBI and PTSD 
through psychologically traumatic events experienced in the warzone.  This high 
incidence of exposure to blast-related head trauma in conjunction with the events 
surrounding the injury makes military service members more prone to the development of 
comorbid CTE-PTSD than civilians.  Post-traumatic stress disorder is known to be a 
psychiatric condition that affects many returning veterans across all branches of the 
military.  Often times, the condition will develop into a chronic condition that will affect 
an individual periodically throughout their life.  Chronic PTSD has been conceptualized 
as “a stress-perpetuating syndrome characterized by hallmark episodes of sensory-
memory re-experiencing of the traumatic events” (Miller and Sadeh 2014).  Though little 
is known concerning the neurobiology of PTSD, clinical manifestations are well 
documented while more and more is being understood about the neurobiology of CTE, 
opening the door for potential cross sectional studies concerning comorbidity. 
 
General	Inflammation	is	Linked	to	Repeated	TBI	and	PTSD	in	the	Brain	
 
 Recent studies suggest that inflammation plays a role in the pathophysiology of 
both CTE and PTSD.  As the brain suffers repeated traumas, the body mounts a system 
wide response that affects the brain, blood vessels, and surrounding blood brain barrier.  
In veterans with PTSD, Bersani et al. showed that psychiatric, physical, and biological 
aspects of PTSD may be associated with dysfunctions in several cellular processes such 
as nitric oxide, a chemical integral in vasodilation among other functions, production.  It 
was shown that global arginine bioavalibility measures, a marker for nitric oxide 
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capacity, were lower in veterans suffering from PTSD and are negatively associated with 
some markers of inflammation and PTSD symptom severity (Bersani et al. 2016).  
Additionally, persistence of PTSD symptoms are known to be associated with accelerated 
aging due to the presence of chronic inflammation in the brain (Passos et al. 2017).  
Although studies concerning the role of cytokines and interferons, key signaling 
molecules in inflammatory processes, have yielded mixed results for PTSD, other studies 
assessing diseases such as schizophrenia, major depressive disorder and bipolar disorder 
have shown increased levels for these molecules (Passos et al. 2017).  However, these 
mixed results could be caused by “the use of psychotropic or anti-inflammatory 
medication, comorbidity with other psychiatric disorders, concurrent inflammatory 
disease, time elapsed since the traumatic even, severity of PTSD symptoms, and type of 
assay used.” (p. 10003; Passos et al. 2017)  Following a meta-analysis review conducted 
by Passos et al., it was found that interleukin 1β, interleukin 6, interferon γ and tumor 
necrosis factor α were all elevated in PTSD patients compared to healthy subjects (Passos 
et al. 2017).  These cytokines are responsible for controlling inflammation but also cause 
decreases in neurogenesis, which can lead to CNS volume loss, suggesting that the 
chronic inflammation is an integral part of the PTSD disease process (Passos et al. 2017).   
The primary injury sustained in a TBI causes an acute inflammatory response 
with a cellular response mounted in the brain that differs depending on the type of injury, 
either focal or diffuse.  In a focal injury, early infiltration of neutrophils occurs, usually 
peaking after a few days, and is followed by the migration of macrophages and 
lymphocytes, with activation and movement of microglia and astrocytes and resolves 
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about ten days post injury (Collins-Praino and Corrigan 2017).  In a diffuse injury, no 
neutrophil infiltration occurs and macrophage and microglial accumulation and 
astrocytosis mainly occurs in the white matter tracts, peaking at around fourteen days 
post-injury (Collins-Praino and Corrigan 2017).  The microglia and astrocytes mainly 
play a neuroprotective role following injury by cleaning up damaged cell debris and 
releasing cytokines, with phenotypic subpopulations of microglia doing various jobs.  
Upon injury, M1 microglia promote a classic pro-inflammatory state by releasing pro-
inflammatory cytokines and oxidative metabolites (Collins-Praino and Corrigan 2017).  
At the same time, M2 microglia help to remodel tissue and suppress the inflammatory 
response being mounted to keep it under control (Collins-Praino and Corrigan 2017).  
However, prolonged M1 activation, such as in repeated TBI, can hamper repair and allow 
tissue damage to persist causing a chronic state (Collins-Praino and Corrigan 2017).   
In addition to a primary injury, there can also be the initiation of a secondary 
pathophysiological cascade characterized by “excitotoxicity, the generation of free 
radicals and lipid peroxidation, mitochondrial dysfunction, swelling and loss of 
astrocytes, axonal swelling and neuronal injury.” (Bogoslovsky et al. 2016)  This 
repetitive post-traumatic neuroinflammation can then lead to brain edema formation and 
the potential for secondary brain injury mediated by the contact-kinin system, a system 
primarily working via activated factor XII in the blood (Hopp et al. 2017).  When this 
response is initiated by the secondary injury, there is potential for alterations in both 
metabolism and cerebral blood flow, axonal lysis and breakdown with parenchymal 
accumulation of tau and amyloid beta, demyelination, axonal degeneration and 
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programed cell death through caspase-3 activation (Bogoslovsky et al. 2016).  The 
responding microglia are activated either transiently or persistently in the first days to a 
week after the initial injury (Blennow et al. 2016).  Once healing begins, microglia then 
migrate to and proliferate at the site of injury where they release cytokines such as 
interleukin 1 (IL-1), IL-6, and tumor necrosis factor α (TNF), all of which help to repair 
and regenerate the central nervous system tissue that has been damaged (Bogoslovsky et 
al. 2016).  Although these cytokines are released for repair, they may also produce a toxic 
environment for neurons and other glial cells, such as astrocytes, thereby causing further 
damage and inhibiting neurogenesis (Passos et al. 2015).  This inhibition of neurogenesis 
in turn causes central nervous system volume loss, notably in the hippocampus, prefrontal 
cortex, and middle temporal gyrus (Passos et al. 2015).  Additionally, the potential 
presence of IL-1β is thought to have negative effects on memory formation and 
consolidation, both of which are physiological functions dysregulated during PTSD 
suggesting inflammation from TBI possibly causes these effects (Passos et al. 2015).  
This primary neuroinflammatory response is short lived, but repeated TBI may lead to 
chronic neuroinflammation that “induces a self-perpetuating cycle with longstanding 
activation of microglia, including sustained release of inflammatory mediators” and 
thereby perpetuates the toxic environment (Cherry et al. 2016).  This perpetual low-grade 
inflammation is in the absence of infection and can possibly explain the link between 
PTSD and CTE with other diseases in which immune activation plays a key role (Hänsel 
et al. 2010).  This chronic systemic inflammation can also accelerate ageing due to 
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reactive oxygen species mediating exacerbation of telomere dysfunction and cell 
senescence (Jurk et al. 2014). 
 
Inflammation’s Effect on the Blood Brain Barrier 
 When acute inflammation occurs in the brain, it not only damages neurons and 
other glial cells, but also the integrity of the blood brain barrier.  This damage contributes 
to “the propagation of vasogenic and cytotoxic edema and allows the infiltration of 
inflammatory cytokines and chemokines into the brain parenchyma, thereby promoting 
the infiltration of inflammatory cells.” (p. 37; Bogoslovsky et al. 2016)  The expansion of 
the brain volume through edema impacts both morbidity and mortality related to TBI due 
to an increase in intracranial pressure and inhibits clearance of toxic metabolites, such as 
p-tau, from the cerebral tissue (Bogoslovsky et al. 2016).   
In the presence of chronic inflammation, the permeability of the BBB can 
increase, allowing for cytokine, such as IL-6 and TNF- α, over-activity causing microglia 
over-activation, destruction of non-injured neurons, and neuronal loss (Devoto et al. 
2016).  This impaired BBB and neuronal loss also contributes to the build up and 
deposition of tau, particularly in the sulci of the frontal cortex around damaged vessels 
and their perivascular space.  The lesions cause damage to astrocytes in the area causing 
their end feet to recede and the loss of aquaporin-4, an important channel for movement 
of fluids in and out of blood vessels.  
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Astrocytes Play a Major Role in the CTE Disease Process 
Astrocytes are the most numerous cells in the central nervous system and perform 
a variety of tasks from axon guidance and synaptic support to control of the blood brain 
barrier and blood flow (Blackburn et al. 2009).  They do not just provide tropic, 
metabolic, and structural support for neurons, but they also take part in neuronal-glial 
communication, synaptic signaling, regulation of blood flow and can influence neuronal 
stem cells (Blackburn et al. 2009).  They secrete growth-promoting and inhibiting 
molecules, such as proteoglycans and glycoproteins, to make up the extracellular matrix 
important for glial boundaries and axon guidance (Blackburn et al. 2009).  Astrocytes 
have many branches that are used to enclose synapses, neuronal somata or bundles of 
axonal internodes, which is important for maintaining synaptic homeostasis (Blackburn et 
al. 2009).   
Most importantly for CTE, however, astrocytic end feet surround the endothelial 
cells that line cerebral microvessels and form part of the BBB.  Of the many subtypes of 
astrocytic cells, eight are believed to be specifically involved with blood vessels 
(Blackburn et al. 2009).  These cells interact with the endothelial cells and help to 
regulate the roles of the endothelial cells including tight junction formation, the 
localization of transporters and the production of specialized anti-oxidant enzymes 
(Blackburn et al. 2009).  They also secrete angiogenic factors such as angiopoetin 1 and 
neurotrophins, such as transforming growth factor- β, that play a role in development of 
new brain capillary function (Blackburn et al. 2009).  In return, the endothelial cells 
secrete leukemia inhibitory factor, which is able to induce astrocyte differentiation and 
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links astrocyte development to these endothelial cells and the BBB (Blackburn et al. 
2009).   
 The most important part of the astrocytes involved in blood flow regulation and 
the BBB are the end feet that project off the branches of the cell.  These end feet are 
responsible for contacting the blood vessels and have a distinct structure of 
intramembraneous particles for use in active material exchange (Blackburn et al. 2009).  
These particles consist of aquaporin-4 (AQ4), the glucose transporter 1 (GLUT-1), and 
the potassium channel kir4.1 and are involved in ion, glucose, and water homeostasis (Ke 
et al. 2001).  Due to the dynamic nature of the BBB, it can be remodeled by a number of 
factors including inflammatory cytokines, angiogenic factors, glutamatergic toxicity, 
hypoxia, and oxidative stress (Drewes 1998).  These factors can cause neurons to release 
glutamate, which then is able to work on astrocytes via the mGLuR5 receptor.  When the 
mGLuR5 receptor is activated on the astrocytes, they release COX-1 metabolic products 
which in turn cause vasodilation of capillaries (Takano et al. 2006).  This in turn results 
in astrocytes being able to control the permeability of the BBB to nutrients and metabolic 
products (Blackburn et al. 2009).  
 Since astrocytes are so closely involved with the BBB and able to change its 
permeability, they can cause edema due to damage resulting from repeated mTBI.  The 
damage sustained can cause astrocytic dysfunction and result in the destruction or 
replacement of the end feet with scarring from reactive astrocytes disrupting homeostasis 
and clearance of particles.  This in turn allows for the build-up of toxic metabolites such 
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as p-tau and further progresses the neurodegeneration present during the CTE disease 
process through the interference with the BBB. 	  
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SPECIFIC AIMS 
 
 The initial objective of this project was to analyze the disruption of aquaporin-4 
around cerebral blood vessels due to chronic traumatic encephalopathy.  Previous studies 
have show that the deposition and build-up of toxic metabolites, such as p-tau, in areas of 
the brain, primarily the prefrontal cortex, are a key physiopathological symptom of 
chronic traumatic encephalopathy caused by repeated mTBI.  Studies have also shown 
that the perpetual state of inflammation can cause severe changes in the brain including 
neuronal loss, axonal damage, and astrocytosis due to the amount of edema occurring and 
the chronic milieu of inflammatory cytokines.  Knowing this, the objective was to 
determine if this p-tau deposition in the sulci of the prefrontal cortex has any effect on the 
astrocytes present in the area and how any effect may interrupt the distribution of 
aquaporin-4 around the vessels in lesional areas with the hypothesis that lesional areas 
will have markedly reduced distribution of aquaporin-4 around the vessel signifying 
damage to the blood brain barrier. 
 The secondary objective of this study was to determine if any unique 
physiopathological biomarkers exist in PTSD and if the effects of CTE are exacerbated 
when present comorbidly with PTSD.  Studies on returning veterans from military 
conflicts have shown that repeated mTBI plays a role in the formation of both PTSD and 
CTE leading to the thought that comorbidly the diseases may compound the effects of 
each other.  It was hypothesized that comorbidly the disease effects would be 
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compounded and that PTSD would have unique physiopathological signatures in the 
prefrontal cortex separate but simultaneously present with CTE in a comorbid cohort.  
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METHODS  	
Study Subject Demographics and Selection 
This study used histologic analysis of cortical tissue samples from a brain bank to 
compare aquaporin-4 around cerebral blood vessels in samples from patients with CTE 
(CTE-only), or CTE comorbid with PTSD (CTE+PTSD).		The study was approved by the 
VA Boston Healthcare System (VABHS) Institutional Review Board. 
In order to effectively assess the disruption of aquaporin-4 around cerebral vessels 
during both CTE and PTSD, two cohorts were selected using brains provided by both the 
Lieber Brain Institute and the VA National PTSD Brain Bank.  The Lieber Brain Institute 
provided only one hemisphere of each brain with the institute retaining the other 
hemisphere for their own use.  The two cohorts established were a CTE only cohort and a 
comorbid CTE/PTSD cohort to effectively evaluate the presence of unique markers in 
PTSD, as well as the effect of CTE/PTSD comorbidity.  The subjects were selected to 
ensure neuropathological change due to CTE, PTSD, or both along with controls for each 
cohort.   
Each subject used in the study was male with a prior history of head trauma 
resulting from either sports involvement, such as football, or military service resulting in 
concussion from blasts or blunt trauma.  All subjects were confirmed to have a history of 
neurodegenerative disease through a retrospective clinical analysis and neuropathological 
evaluation.  The experimental subjects were selected for having a history of head injury 
through mTBI, with age-matched controls being without a history of head injury. 
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For the CTE-only cohort stained for smooth muscle actin, a total of 15 
experimental subjects and 6 controls were used ranging in age of death from 14-82 years 
of age and suffering from varying severity of CTE from stage II through stage IV in order 
to see lesional damage (Table 1).  For the GFAP stained study, the CTE/PTSD cohort 
contained a total of six subjects ranging in age from 29-50 with varying levels of CTE 
severity and positive PTSD diagnoses.  Additionally, 5 controls were used that had no 
signs of CTE or PTSD.  Rounding out the study, the CTE only cohort consisted of 9 
subjects ranging in age from 25-84 years of age (Table 2).  Each cohort contained 
controls with similar neurodegenerative diseases such as AD to ensure the unique 
pathology observed in the individual cohorts. 
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Patient Sex Age Sport  Military 
Service 
CTE  
1 M 19 HS Football No No  
2 M 16 HS Football No No 
3 M 62 Pro Boxing No Yes 
4 M 67 NFL  No Yes 
5 M 34 Amateur Athlete Yes Yes 
6 M 52 NFL No Yes 
7 M 25 HS 
Football/Basketball 
No Yes 
8 M 14 HS Football No No 
9 M 25 College Football No Yes 
10 M 79 NFL No Yes 
11 M 68 NFL No Yes 
12 M 73 NFL No Yes 
13 M 76 Boxing No Yes 
14 F 64 No Data No No 
15 F 75 No Data No No 
16 M 75 NFL Yes Yes 
17 M 75 NFL No Yes 
18 M 61 Pro Boxing No Yes 
19 M 51 None Yes No 
20 M 82 NFL No Yes 
21 M 22 HS Football No No 
Table 1. CTE-Only Patient Information. This table gives general information 
regarding the subjects studied for the arterial lesion portion of the project. Subjects had 
either mTBIs suffered through sport contact, military deployment, or both. Subjects also 
showed varying stages of CTE or no disease. 
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Patient Sex Age Sport Military 
Service 
CTE PTSD 
1 M 32 College 
Football 
Yes Yes Yes 
2 M 44 College 
Football 
Yes Yes Yes 
3 M 40 None Yes No Yes 
4 M 47 Semi-Pro 
Rugby 
Yes Yes Yes 
5 M 64 College 
Football 
Yes Yes Yes 
6 M 49 NFL Yes Yes Yes 
7 M 76 No Data No No No 
8 M 83 No Data No No No 
9 M 84 No Data No No No 
10 M 69 No Data No No No 
11 F 81 No Data No No No 
12 M 25 College 
Football 
No Yes No 
13 M 49 NFL No Yes No 
14 M 70 NFL No Yes No 
15 M 79 NFL No Yes No 
16 M 68 NFL No Yes No 
17 M 73 NFL No Yes No 
18 M 76 Boxing No Yes No 
19 M 67 NFL No Yes No 
20 M 52 NFL No Yes No 
Table 2. CTE+PTSD Comorbidity Study Patient Information. This table gives the 
data on the CTE-PTSD comorbidity part of this study. The data represented includes sex, 
age, sport involvement, military service, and CTE and PTSD diagnoses.   
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Tissue Acquisition 
The tissue acquisition was performed according to McKee et al. (McKee et al. 
2013).  In brief, the tissue samples used in this project were collected at the Edith Nourse 
Rogers Memorial Veterans Hospital in Bedford, Massachusetts according to the PTSD 
Brain Bank tissue handling protocol for Lieber Institute tissue.  The brain and spinal cord 
underwent processing involving comprehensive photograph documentation, histological 
processing, neuropathological analysis, and regional immunostaining using established 
brain banking methods according to the NIH-funded Alzheimer’s Disease Centers and 
the VA Boston brain banks.  The tissue was cut into 0.5 cm blocks and fixed in PLP for 
seven days.  Following fixation, the blocks were processed into paraffin and cut into 5 
µm sections mounted on glass slides.  The remaining tissue was frozen on aluminum 
plates cooled with dry ice. 
The frontal cortex was the primary region of interest prepared for analysis on this 
project.  The tissue samples were prepared from the block taken from the dorsolateral 
frontal cortex of the hemispheres provided by the Lieber Institute.  All banked CNS 
cases, either normal or diseased, were neuropathologically evaluated to confirm clinical 
diagnoses and the presence of any neurological conditions only revealed post-mortem.  
All formalin-fixed tissue blocks were sent to VABHS for gross evaluation and 
microscopic diagnostic analyses by Drs. McKee, Huber and Stein. 
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Immunohistochemistry 
In order to microscopically analyze the tissue samples after processing, the slides 
were stained with luxol-fast blue, hematoxylin, and eosin (LHE), and the antibodies used 
were: phosphorylated tau (AT8), Aß protein, glial fibrillary acidic protein (GFAP), 
smooth muscle actin (SMA) and alpha-synuclein.  AT8 (Innogenetics, Inc.) stains 
positively for phosphorylated tau to detect the presence of neurofibrillary tangles (NFT), 
neuropil threads, Pick bodies, oligodendroglial and glial NFT and ballooned neurons.  Aß 
protein (Dako) was used in order to detect amyloid ß deposition as plaques, 
cerebrovascular amyloid, and amorphous deposits.  Alpha-synuclein (Chemicon) detected 
the presence of Lewy bodies, Lewy neurites, pale bodies, and neuronal or cytoplasmic 
inclusions.  GFAP (Boehringer-Mannheim) stained for the presence of astrocytosis.  
SMA was important for the staining of smooth muscle to distinguish arterial and venous 
structures.  Prior to immunostaining for Aß and alpha-synuclein, a formic acid 
pretreatment was used to break the protein cross-links to reveal the antigens and epitopes 
in the paraffin-fixed samples and enhance the antibody staining intensity. 
 
Immunofluorescence and Image Acquisition 
 
 Image acquisition was performed using an Aperio ScanScope AT bundle 
slide scanner (Leica), MAC 6000 system (MBF Bioscience), Axio Imager 2 research 
microscope (Zeiss), ApoTome.2 (Zeiss), Stereology system (MBF Bioscience), and X-
Cite XT120L (Lumen Dynamics) for the CTE only cohort and a Discovery.V12 
fluorescent stereomicroscope (Zeiss), and Ultima IV multiphoton microscope (Bruker) 
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fitted with a Insight DS+ two photon laser (Spectraphysics) for both the CTE/PTSD 
comorbid and CTE only cohorts.  For the CTE-only cohort, the image was originally 
acquired at 2.5x zoom using the virtual tissue scan function to get an image of the entire 
slide.  This virtual scan image was then used to locate both arterial and venous structures, 
often in the depths of the sulcus.  For each sample, multiple arterial and venous lesions 
were imaged as well as non-lesional areas when present both at the base of the sulcus and 
deep in the cortical tissue.  Once an area had been located, the site was imaged at 20x 
zoom taking a maximum intensity z stack ranging from 13-20 images, using 2 micron 
sections, depending on the thickness of the area to visualize the various levels of the 
tissue in question.   
 
Statistical Analysis Methods 
 Once the images had been acquired, they were imported into the FIJI (Image j) 
and Imaris programs for processing.  The images were optimized and a line function was 
used in FIJI to form a graph of the aquaporin density around the imaged vessels.  This 
data was then used to determine if there was knockdown of aquaporin density 
surrounding the vessels as expected to determine if damage had occurred due to the tau 
buildup.  Using Imaris, colocalization channels were built for the vessel fluorescence to 
determine the location of the AT8 in conjunction with the astrocytes.  Using the overlay 
of the colocalization channel, each image was quantified for the total number of NFT, 
astrocytes, astrocytic nuclear tau, and astrocytic diffuse tau present.  To keep uniformity, 
the count was performed within 200 microns of the vessel in question.  All of the 
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acquired data was then compiled into Excel and statistical methods, specifically an 
unpaired t-test for 2 samples assuming unequal variance, were used to analyze the data. 
 When acquiring and processing final figure images, Imaris was used to optimize 
the image parameters and to acquire the final picture.  Images used were given identical 
parameters and all transformations performed were done so in a linear fashion.   
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RESULTS 	
Aquaporin-4 Density in Astrocytes is Redistributed Around Vessels During CTE 
 After analysis of the arterioles and venules in the pre-frontal cortex for the 
subjects in the CTE only cohort, it was found that aquaporin-4 density is significantly 
reduced around both arterial and venous lesional vessels (Figure 2).  Each image was 
assessed for total number of astrocytes, number of neurofibrillary tangles present, and 
amount of both diffuse and astrocytic tau using colocalization channels.  It was found that 
there is a statistically significant increase in NFTs localizing to pre-frontal cortical 
arterioles due to CTE.  However, the total increase in number of astrocytes as well as the 
amount of astrocytic p-tau around venules was not found to be statistically significant 
(Figures 3-5).  The statistics used to analyze this data were performed in Excel using an 
unpaired t-test for two samples assuming unequal variance. For the measure of the tau 
positive astrocytes around venules (Figure 3), 14 total observations were made (6 
arteriole, 8 venous) with means of 24.69 for arterioles and 39.44 for venules.  A standard 
deviation of 18.56 was found for arterioles and 19.43 for venules with p=0.177 
(significance being p≤0.05).  For the measure of astrocyte count around venules during 
CTE (Figure 4), 14 total observations were made (6 arteriole, 8 venous) with means of 
27.89 and 39.38 being reported respectively.  Standard deviations of 14.41 for arterioles 
and 10.10 for venules were found with p=0.129.  For the statistically significant finding 
on neurofibrillary tangles localizing to arterioles in CTE (Figure 5), the same number of 
observations as above were used with the means being 1.53 for arterioles and 0.25 for 
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venules.  The standard deviations used were 1.19 and 0.46 for arterioles and venules 
respectively with a p=0.046. 
 
 
Figure 2. Tau Pathology is Associated with Aquaporin-4 Redistribution Around 
Cortical Arterioles. In this figure it is demonstrated that lesional arterioles have a 
knockdown of aquaporin-4 immediately around the vessel as compared to a healthy 
arteriole.  This supports the theory that p-tau lesions cause redistribution of aquaporin-4. 
Images scaled to 80 microns. 	  
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Figure 3. Tau Positive Astrocytes Do Not Show a Statistically Significant Increase 
Around Venules in CTE. This figure depicts the count of tau positive astrocytes around 
both arterioles and venules in the pre-frontal cortex of the CTE-only cohort. The increase 
was found to not be statistically significant. 	  
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Figure 4. Astrocytes Do Not Show a Statistically Significant Increase Around 
Venules in CTE. This figure depicts the total perivascular astrocyte count around both 
arterioles and venules in the pre-frontal cortex of the CTE-only cohort. It was found that 
there was not a statistically significant increase around the venules.  	 	
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Figure 5. Neurofibrillary Tangles Localized to Arterioles in CTE. This figure depicts 
the total count for neurofibrillary tangles surrounding both arterioles and venules in the 
CTE-only cohort. The total number of neurofibrillary tangles surrounding arterioles was 
found to have a statistically significant increase as compared to venules for CTE.   
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Aquaporin-4/GFAP Astrocyte Reaction to P-tau in Depth of Sulcus 
 Following analysis of the CTE-only and CTE+PTSD cohorts, it was found that p-
tau was more readily deposited in the depths of the sulci of the pre-frontal cortex due to 
the unique forces caused by repeated mTBI (Figure 6).  In the two cohorts, it was seen 
that when the aquaporin-4 astrocytes were knocked down due to the repeated mTBI, 
GFAP positive astrocytes proliferated in their place in a process similar to scarring.  In 
the controls, however, GFAP proliferation was not observed in the depths of the pre-
frontal cortical sulci (Figure 6).  Although it was expected that the aquaporin-4 would be 
knocked out around vessels due to the tau deposition resulting from repeated mTBI, the 
proliferation of GFAP was not expected but makes sense.  The proliferation of GFAP 
into the aquaporin-4 poor areas shows a type of scarring occurring due to the traumas 
experienced while the aquaporin-4 is still expressed immediately around the edge of the 
vessel, potentially from the endothelial cells compensating for the loss of astrocytic end 
feet. 	  
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Figure 6. Aquaporin-4/GFAP Astrocyte Reaction to Presence of Tau in Depth of 
Sulcus. This figure demonstrates the difference between a control case lacking p-tau 
deposition and an experimental CTE case with heavy deposition. In the experimental 
case, the heavy pathology results in GFAP proliferation and loss of aquaporin-4 directly 
around the depth of the pre-frontal cortical sulcus. Images scaled to 50 microns.  
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CTE-PTSD Comorbidity Assessment  
 Although CTE has a unique pathophysiological signature in terms of p-tau 
deposition in the pre-frontal cortex and hippocampus, PTSD was not found to 
significantly compound the disease when comorbidly present with CTE nor to have a 
unique biomarkers present (Figure 7).  As can be seen in Figure 7, the comorbid cases did 
not have a similar amount of p-tau deposition.  Additionally, the comorbid samples 
showed a greater amount of GFAP but also aquaporin-4, making it difficult to say 
directly that the comorbidity causes an increase in glial scarring. 
 Following full analysis of all samples, it was shown that, overall, aquaporin-4 
surrounding lesional vessels was reduced in the immediate area surrounding the vessels 
in question (Figure 8A).  All vessels measured were within the range of 40-60 microns 
and all measures were done over about 200 microns for uniformity.  In contrast, 
aquaporin-4 around nonlesional vessels was found to be much higher signifying that p-
tau deposition due to repeated mTBI has a negative effect on both astrocytes and 
aquaporin-4 distribution (Figure 8B).  When aquaporin-4 averages were taken for both 
lesional and nonlesional vessels and compared, it was shown that overall nonlesional 
vessels have a higher density of aquaporin-4 around them suggesting a healthier BBB and 
clearance ability (Figure 8C). 
 In addition to aquaporin-4 density, GFAP density was also measured.  As 
expected, the reverse was found compared to the aquaporin-4 densities.  It was seen that 
lesional vessels tended to have a greater density of GFAP surrounding the vessel, 
suggesting the proliferation of GFAP in the damaged area in place of aquaporin-4 (Figure 
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9A).  Although a couple measures for GFAP density surrounding the nonlesional vessels 
trended higher, overall the density of GFAP surrounding nonlesional vessels was lower 
(Figure 9B).  When the GFAP averages for both the lesional and nonlesional vessels were 
compared, they appeared to be roughly the same, with GFAP being higher away from the 
vessels for the lesional measure and higher for the nonlesional closer to the vessel (Figure 
9C).  This result could be due to the higher nonlesional measure skewing the average, 
however. 
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Figure 7. Aquaporin-4/GFAP Distribution in Frontal Cortex during CTE and 
Comorbid Disease Processes. This figure demonstrates the difference between CTE, 
CTE-PTSD comorbid and control cases. The CTE shows a higher amount of p-tau and 
proliferation of GFAP in the areas where aquaporin-4 is knocked down. Although the 
comorbid case shows a higher intensity of GFAP, the surrounding area is both lower in p-
tau and higher in aquaporin-4. Images scaled to 50 microns.  
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C. 
Figure 8. Aquaporin-4 Density Assessments for Lesional and Nonlesional Vessels. 
This figure shows the aquaporin-4 density plots for both the lesional and nonlesional 
vessels as well as the compared averages of the two. 8A shows an overlay of multiple 
lesional vessels demonstrating the spike in aquaporin-4 density immediately around the 
vessel suggesting knockdown of the aquaporin-4 around the vessels due to the disease 
process. 8B contrasts 8A by depicting the densities around nonlesional vessels. 8C shows 
an averaged overlay depicting higher overall aquaporin-4 levels for nonlesional vessels. 
For each graph the middle of the vessel is represented by the center of the dip. 	  
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C. 
Figure 9. GFAP Density Plots for Lesional and Nonlesional Vessels. This figure 
shows the GFAP density plots for both the lesional and nonlesional vessels as well as the 
compared averages of the two. 9A shows an overlay of multiple lesional vessels 
demonstrating the increase in GFAP for lesional vessels, potentially in place of the 
knocked out aquaporin-4. 9B contrasts 9A by depicting the densities around nonlesional 
vessels, with an overall lower level of GFAP around healthy vessels. 9C shows an 
averaged overlay depicting similar levels of GFAP, with higher density for the lesional 
vessels away from the center and higher levels for nonlesional closer to the center of the 
vessel. For each graph the middle of the vessel is represented by the center of the dip. 
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DISCUSSION 
 
 Many studies have looked at the pathophysiological signs and symptoms of CTE 
and also the clinical manifestations as well as the psychological effects of PTSD.  
However, there have not been many studies into the neurobiology of PTSD and how it 
interacts with CTE.  The purpose of this study was two-fold.  This study aimed to analyze 
both the effects of CTE on aquaporin-4 distribution and the BBB in the pre-frontal cortex 
as well as the unique interaction of PTSD with CTE to determine any compounding 
effects or unique biomarkers for PTSD. 
 
Effect of Chronic Traumatic Encephalopathy on Aquaporin-4 Density in Pre-Frontal 
Cortex 
As was initially hypothesized at the beginning of the study, it was found that CTE 
caused by repeated mTBI does have an effect on blood vessels in the pre-frontal cortex.  
It was found that astrocytes are negatively affected by the CTE disease process due to the 
amount of p-tau deposition occurring.  Although the change in total number of astrocytes 
and the amount of p-tau around venules were found to not be statistically significant, it 
was found that the increase in neurofibrillary tangles localizing to arterioles in the pre-
frontal cortex was significant, suggesting these NFTs play a large role in the destruction 
and disruption of the aquaporin-4 bearing astrocytes in the area.  In addition to finding 
this effect, this study also showed that when aquaporin-4 is disrupted, a proliferation of 
GFAP around the affected vessel occurs.  This signifies a potential scarring pattern 
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caused by the traumas suffered that lead to CTE and may help to further understand how 
this disease progresses in vivo.  
 
Unique Biomarkers and Comorbid Effect of PTSD 
Contrary to the initial hypothesis that PTSD will show unique biomarkers 
separate from CTE when analyzed comorbidly, this study found no significant pathology 
caused by PTSD when occurring simultaneously with CTE.  Additionally, no definitive 
differences were found to suggest that PTSD significantly exacerbated the pathology 
present during CTE.  Although these results refute the initial hypothesis, the inability to 
look at live tissue over a range of time does not rule out the potential comorbid effects of 
PTSD when comorbidly occurring with CTE.  The focused deposition of p-tau caused 
damage to the astrocytes in the area, thus affected the distribution of aquaporin-4 directly 
around the sulci.  This astrocytosis and GFAP proliferation not only damaged the BBB of 
the pre-frontal cortical tissue in the surrounding area but also impacted the clearance 
ability of the astrocytes in the depths of the sulci by disrupting the end feet of the 
astrocytes contacting the surrounding vessels.  This damage would then lead to greater 
buildup of the toxic p-tau and further the disease processFurther in vivo analysis may 
show a compounding effect does occur due to the chronic state of inflammation caused 
by both diseases and their negative effects on both cerebral volume and clearance ability.  
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Limitations of This Study  
Due to the nature of this study and the way in which the samples were analyzed, 
limitations were present.  Because the samples were being analyzed with a microscope 
from a fixed slide, the study was hampered by plane of section.  Although the vessels 
imaged were chosen carefully, the plane of section sometimes caused folds or was only 
able to represent a small part of the vessel hampering the ability to fully understand the 
vessel’s immediate environment.  Another major limitation for this study in regard to 
PTSD was the lack of current knowledge about pathophysiological markers for PTSD.  
Not having prior research to base the study on, it was unknown which area unique 
biomarkers could potentially be found in and where the study should be more heavily 
focused.  A final limitation of this study was the smaller group size.  Having a smaller 
group size made it more difficult to both find statistical significance as well as to get a 
wide sampling of the disease states.  The lack of comorbid CTE-PTSD cases can be 
contributed to the aggressive nature of CTE and the general lack of comorbid brains 
available.  Larger group sizes will give a better sampling of comorbid effects of CTE and 
PTSD as well as a larger base to search for unique biomarkers for PTSD. 
 
Implications for Future Directions 
 The results of this study have a few implications for future research.  
Because it was found that CTE affects astrocytes in the immediate perivascular space 
surrounding arterioles in the pre-frontal cortex, it would be interesting for future studies 
to look at CTE cases compared to healthy cases to determine if the aquaporin-4 found on 
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the vessels is being generated by the affected astrocytes or if there is an increase in 
aquaporin-4 production by the endothelial cells themselves to compensate for the 
knockdown.  Another interesting future direction would be to analyze the effect of 
neuronal tau on Map2, a protein produced by dendrites important for neuron stabilization 
and development.  By analyzing this effect, it would give greater understanding to how 
CTE and/or PTSD affect neuron generation.  
	44 
REFERENCES 
 
American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental 
Disorders: DSM-5. Washington, D.C.: American Psychiatric Association. 
 
Bersani, Francesco Saverio, Owen M. Wolkowitz, Daniel Lindqvist, Rachel Yehuda, 
Janine Flory, Linda M. Bierer, Iouri Makotine, et al. 2016. “Global Arginine 
Bioavailability, a Marker of Nitric Oxide Synthetic Capacity, Is Decreased in 
PTSD and Correlated with Symptom Severity and Markers of Inflammation.” 
Brain, Behavior, and Immunity 52 (February): 153–60. 
doi:10.1016/j.bbi.2015.10.015. 	
Blackburn, Daniel, Siranush Sargsyan, Peter N. Monk, and Pamela J. Shaw. 2009. 
“Astrocyte Function and Role in Motor Neuron Disease: A Future Therapeutic 
Target?” Glia 57 (12): 1251–64. doi:10.1002/glia.20848. 	
Blennow, Kaj, David L. Brody, Patrick M. Kochanek, Harvey Levin, Ann McKee, 
Gerard M. Ribbers, Kristine Yaffe, and Henrik Zetterberg. 2016. “Traumatic 
Brain Injuries.” Nature Reviews. Disease Primers 2: 16084. 
doi:10.1038/nrdp.2016.84. 	
Bogoslovsky, Tanya, Jessica Gill, Andreas Jeromin, Cora Davis, and Ramon Diaz-
Arrastia. 2016. “Fluid Biomarkers of Traumatic Brain Injury and Intended 
Context of Use.” Diagnostics (Basel, Switzerland) 6 (4). 
doi:10.3390/diagnostics6040037. 	
Cherry, Jonathan D., Yorghos Tripodis, Victor E. Alvarez, Bertrand Huber, Patrick T. 
Kiernan, Daniel H. Daneshvar, Jesse Mez, et al. 2016. “Microglial 
Neuroinflammation Contributes to Tau Accumulation in Chronic Traumatic 
Encephalopathy.” Acta Neuropathologica Communications 4. 
doi:10.1186/s40478-016-0382-8. 	
Collins-Praino, Lyndsey E., and Frances Corrigan. 2017. “Does Neuroinflammation 
Drive the Relationship between Tau Hyperphosphorylation and Dementia 
Development Following Traumatic Brain Injury?” Brain, Behavior, and Immunity 
60 (February): 369–82. doi:10.1016/j.bbi.2016.09.027. 	
DePalma, Ralph G. Ch. 2: Combat TBI: History, Epidemiology, and Injury Modes. Brain 
Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. CRC 
Press; Boca Raton, FL: 2015. 		
 
	45 
Drewes	LR.	1998.	An	Introduction	to	the	BBB,	methodology,	biology	and	pathology.	UK:	Cambridge	University	Press	
 
Devoto, Christina, Lindsay Arcurio, Joseph Fetta, Mary Ley, Tamar Rodney, Rebekah 
Kanefsky, and Jessica Gill. 2016. “Inflammation Relates to Chronic Behavioral 
and Neurological Symptoms in Military with Traumatic Brain Injuries.” Cell 
Transplantation, October. doi:10.3727/096368916X693455. 	
Friedman, Matthew J. 2013. “Finalizing PTSD in DSM-5: Getting Here from There and 
Where to Go next.” Journal of Traumatic Stress 26 (5): 548–56. 
doi:10.1002/jts.21840. 	
Gennerelli, T.A. Textbook of Traumatic Brain Injury. 2nd Ed. American Psychiatric 
Publishing, Inc.; Arlington, VA: 2005. 	
Ghajari, Mazdak, Peter J. Hellyer, and David J. Sharp. 2017. “Computational Modelling 
of Traumatic Brain Injury Predicts the Location of Chronic Traumatic 
Encephalopathy Pathology.” Brain: A Journal of Neurology 140 (Pt 2): 333–43. 
doi:10.1093/brain/aww317. 	
Hänsel, Alexander, Suzi Hong, Rafael J. A. Cámara, and Roland von Känel. 2010. 
“Inflammation as a Psychophysiological Biomarker in Chronic Psychosocial 
Stress.” Neuroscience and Biobehavioral Reviews 35 (1): 115–21. 
doi:10.1016/j.neubiorev.2009.12.012. 	
Hopp, Sarah, Marc W. Nolte, Christian Stetter, Christoph Kleinschnitz, Anna-Leena 
Sirén, and Christiane Albert-Weissenberger. 2017. “Alleviation of Secondary 
Brain Injury, Posttraumatic Inflammation, and Brain Edema Formation by 
Inhibition of Factor XIIa.” Journal of Neuroinflammation 14 (1): 39. 
doi:10.1186/s12974-017-0815-8. 	Howlett,	Jonathon	R.	and	Murray	B.	Stein.	Chapter	16:	Post	Traumatic	Stress	Disorder.	Translational	Research	in	Traumatic	Brain	Injury.	CRC	Press;	Boca	Raton,	FL:	2016.		
Jurk, Diana, Caroline Wilson, João F. Passos, Fiona Oakley, Clara Correia-Melo, Laura 
Greaves, Gabriele Saretzki, et al. 2014. “Chronic Inflammation Induces Telomere 
Dysfunction and Accelerates Ageing in Mice.” Nature Communications 2 (June): 
4172. doi:10.1038/ncomms5172. 	
Ke, C., W. S. Poon, H. K. Ng, J. C. Pang, and Y. Chan. 2001. “Heterogeneous Responses 
of Aquaporin-4 in Oedema Formation in a Replicated Severe Traumatic Brain 
Injury Model in Rats.” Neuroscience Letters 301 (1): 21–24. 	
	46 
McKee, Ann C., Robert C. Cantu, Christopher J. Nowinski, E. Tessa Hedley-Whyte, 
Brandon E. Gavett, Andrew E. Budson, Veronica E. Santini, Hyo-Soon Lee, 
Caroline A. Kubilus, and Robert A. Stern. 2009. “Chronic Traumatic 
Encephalopathy in Athletes: Progressive Tauopathy Following Repetitive Head 
Injury.” Journal of Neuropathology and Experimental Neurology 68 (7): 709. 
doi:10.1097/NEN.0b013e3181a9d503. 	
McKee, Ann C., Thor D. Stein, Christopher J. Nowinski, Robert A. Stern, Daniel H. 
Daneshvar, Victor E. Alvarez, Hyo-Soon Lee, et al. 2013. “The Spectrum of 
Disease in Chronic Traumatic Encephalopathy.” Brain 136 (1): 43. 
doi:10.1093/brain/aws307. 	
Miller, Mark W., and Naomi Sadeh. 2014. “Traumatic Stress, Oxidative Stress and 
Posttraumatic Stress Disorder: Neurodegeneration and the Accelerated-Aging 
Hypothesis.” Molecular Psychiatry 19 (11): 1156. doi:10.1038/mp.2014.111. 	
Nock, M. K., I. Hwang, N. A. Sampson, and R. C. Kessler. 2010. “Mental Disorders, 
Comorbidity and Suicidal Behavior: Results from the National Comorbidity 
Survey Replication.” Molecular Psychiatry 15 (8): 868–76. 
doi:10.1038/mp.2009.29. 	
Passos, Ives Cavalcante, Mirela Paiva Vasconcelos-Moreno, Leonardo Gazzi Costa, 
Maurício Kunz, Elisa Brietzke, João Quevedo, Giovanni Salum, Pedro V. 
Magalhães, Flávio Kapczinski, and Márcia Kauer-Sant’Anna. 2015. 
“Inflammatory Markers in Post-Traumatic Stress Disorder: A Systematic Review, 
Meta-Analysis, and Meta-Regression.” The Lancet. Psychiatry 2 (11): 1002–12. 
doi:10.1016/S2215-0366(15)00309-0. 	
Reid, Matthew W., and Carmen S. Velez. 2015. “Discriminating Military and Civilian 
Traumatic Brain Injuries.” Molecular and Cellular Neuroscience, Traumatic 
Brain Injury, 66, Part B (May): 123–28. doi:10.1016/j.mcn.2015.03.014. 	
Stein, Thor D., Victor E. Alvarez, and Ann C. McKee. 2014. “Chronic Traumatic 
Encephalopathy: A Spectrum of Neuropathological Changes Following Repetitive 
Brain Trauma in Athletes and Military Personnel.” Alzheimer’s Research & 
Therapy 6 (1): 4. doi:10.1186/alzrt234. 	
Takano, Takahiro, Guo-Feng Tian, Weiguo Peng, Nanhong Lou, Witold Libionka, 
Xiaoning Han, and Maiken Nedergaard. 2006. “Astrocyte-Mediated Control of 
Cerebral Blood Flow.” Nature Neuroscience 9 (2): 260–67. doi:10.1038/nn1623. 
  
	47 
CURRICULUM VITAE 
	48 
